A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+

Clinical trial NCT07326215 · RECRUITING

Trial details

NCT number: NCT07326215
Sponsor: Vantive Health LLC
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome Acute Kidney Injury

Start date: 2025-12-11
Primary completion: 2026-08-31
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.